Filing Flows › Gossamer Bio (GOSS) › How it makes money
How Gossamer Bio (GOSS) makes money
Gossamer Bio (GOSS) made $9.2M of revenue in the second quarter 2026 (Q2 2026), -20% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $9.2M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $9.2M | -20% |
| Q1 2026 | $17.0M | +72% |
| Q4 2025 | $13.8M | +47% |
| Q3 2025 | $13.3M | +40% |
| Q2 2025 | $11.5M | -88% |
| Q1 2025 | $9.9M | — |
| Q4 2024 | $9.4M | — |
From Gossamer Bio's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Gossamer Bio make money?
Gossamer Bio (GOSS) made $9.2M of revenue in the second quarter 2026 (Q2 2026), -20% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.